LY2811376

LY2811376

CAT N°: 16712
Price:

From 66.00 56.10

Accumulation of the ?-amyloid (A?) peptide in the brain is implicated as the primary cause of neurodegeneration and progression of Alzheimer’s disease.{16791} A? is derived from sequential proteolytic cleavage of the amyloid precursor protein (APP) by ?-secretase (BACE) and ?-secretase.{16790} LY2811376 is a non-peptide inhibitor of BACE1 (IC50 = 239 nM for the synthetic peptide) that demonstrates ~10-fold selectivity over BACE2 and >50-fold selectivity over the aspartyl proteases cathepsin D, pepsin, and renin.{27584} LY2811376 treatment in APP-overexpressing cells and transgenic animal models yields a dose-dependent decrease in A?.{27584} Furthermore, LY2811376 has been reported to reduce C99 and sAPP?, the two primary APP cleavage products generated by BACE1.{27584}

We also advise you

TAF 10 Peptide

TAF 10 Peptide

TAF10 is one of many protein factors or coactivators associated with RNA polymerase II activity.{16903} One vial of this peptide...

€191.00
View